about
Boceprevir for previously treated chronic HCV genotype 1 infectionEffect of bottlenecking on evolution of the nonstructural protein 3 gene of hepatitis C virus during sexually transmitted acute resolving infectionInterleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virusUltra-deep pyrosequencing detects conserved genomic sites and quantifies linkage of drug-resistant amino acid changes in the hepatitis B virus genomeInterferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy GroupThe development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation.[Assessment of the PCR-Southern blot technique for the analysis of viremia in patients with acute hepatitis A]Introduction: thrombocytopenia in chronic liver disease -- treatment implications and novel approaches.Thrombocytopenia associated with chronic liver disease.Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients.Efficacy and safety of boceprevir plus peginterferon-ribavirin in patients with HCV G1 infection and advanced fibrosis/cirrhosis.Safety and efficacy of boceprevir/peginterferon/ribavirin for HCV G1 compensated cirrhotics: meta-analysis of 5 trials.Cirrhosis, liver transplantation and HIV infection are risk factors associated with hepatitis E virus infectionRole of screening in prevention and treatment.Is there a role for interferon in acute viral hepatitis?Hepatitis B virus genome variability and disease progression: the impact of pre-core mutants and HBV genotypes.Clinical application of estimating hepatitis B virus quasispecies complexity by massive sequencing: correlation between natural evolution and on-treatment evolution.Detection of early portal hypertension with routine data and liver stiffness in patients with asymptomatic liver disease: a prospective study.Community-based seroepidemiological survey of hepatitis E virus infection in Catalonia, Spain.Increased tumour necrosis factor alpha production in mesenteric lymph nodes of cirrhotic patients with ascitesComplex Genotype Mixtures Analyzed by Deep Sequencing in Two Different Regions of Hepatitis B Virus.Evidence of an Exponential Decay Pattern of the Hepatitis Delta Virus Evolution Rate and Fluctuations in Quasispecies Complexity in Long-Term Studies of Chronic Delta Infection.Drugs in development for hepatitis B.Quasispecies dynamics in main core epitopes of hepatitis B virus by ultra-deep-pyrosequencingInterleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response.Molecular epidemiology and putative origin of hepatitis C virus in random volunteers from Argentina.Cost-effectiveness of boceprevir in patients previously treated for chronic hepatitis C genotype 1 infection in the United States.Successful use of entecavir for a severe case of reactivation of hepatitis B virus following polychemotherapy containing rituximab.Management of hepatitis C virus genotype 4: recommendations of an international expert panel.Preparing the patient for success: treat or wait?New therapeutic perspectives in HBV: when to stop NAs.Hepatitis C virus genotype 3: a genotype that is not 'easy-to-treat'.Therapy for hepatitis C genotype 3: moving forward.Management of direct-acting antiviral agent failures.Cost-effectiveness of a hepatitis B virus screening strategy to prevent reactivation in patients with hematologic neoplasms.Interferon-free therapies for patients with chronic hepatitis C genotype 3 infection: A systematic review.Ultra-deep pyrosequencing analysis of the hepatitis B virus preCore region and main catalytic motif of the viral polymerase in the same viral genomeManagement of direct antiviral agent failures.Hepatitis C virus genotype 4: Genotype 1's little brother.Sporadic cases of acute autochthonous hepatitis E in Spain.
P50
Q24620576-47370BFF-C297-453E-99FB-B7DD17B52A9AQ27472770-5058E295-E24D-4288-87E0-E43825355291Q28279955-2B6F852D-9F02-479A-B7F8-AE15E805B178Q28484005-D3C796EB-4759-4851-8F9D-0F333872BF25Q29620719-9B1A8B14-2F7F-41EC-9AA1-0555100EBCC1Q30664814-C20F431C-85C3-4482-9218-8645AED13F10Q32060134-D34D446A-C8D0-4D4C-855B-EA2C3F1699ABQ33377122-015C38A0-E1AA-4208-AB98-2DDD95D1AA61Q33379389-F1E42643-901E-40AE-8BB1-8FE7D1F3DAE1Q33395929-4D71A357-A2AF-4A8E-8FE0-165AB7484ED7Q33404560-9D647F1F-0234-49A5-B418-86756B0F5B00Q33414720-4B203839-9467-414D-AB4E-09A60FE59751Q33961593-5FC1D617-8244-487B-89D8-47E329FCD484Q34375683-6F092496-87E0-45AE-B72C-DA831F0D43B4Q34375740-E7753296-22DC-416D-B324-AC9DE3C63FF6Q34491877-8CA51248-030E-4B35-8850-295549D98FACQ34506624-859A3DCD-91B5-4DD9-9875-878DA5907199Q35037878-8822F6CF-4909-404F-94B6-307E6A026706Q35216125-16E4333F-758C-4B65-BB8B-58F66BCEE3DCQ35595814-EF71C23D-2E4D-4CBF-A328-E2057C54284DQ35880685-C09447FA-460E-40AD-8863-9047AC658E5DQ36065068-4BC60631-EDF0-409B-AC99-84F80CC78104Q36201563-146776BB-A86A-4A88-9BCB-8AA0ED56B463Q36395364-4090D472-C614-4A73-94CB-75ED8F01E475Q36457831-7EA5F4F2-CE16-46F1-8E2A-FFDE702F5CA6Q37221506-8B2C1BA4-11F1-443E-AC68-ACF8BF017805Q37286544-15A6FF0A-41E6-4FF2-A6E7-9B49B6B72F0CQ37616336-F6496BB6-E609-454E-AC90-B8EB124672AAQ37840716-3E25E1BA-5CD2-427B-9F33-9AB6E4C1CE9AQ38148906-BF5B8086-8BDB-4137-9BAD-8EE23C84663BQ38174265-4D038966-C87D-49E8-BA8C-F51E384B2AB9Q38249236-CBD146C0-2F7A-488B-9E57-7D83F29E928EQ38476041-55247C0D-AA93-41F8-8C09-A83FA284F6D8Q38572112-4655E1EC-563A-49BF-B52D-86127B4A2C33Q38710187-75003CF3-6745-4215-A895-F90AA10EEB38Q38786225-54FAD35B-5B9F-46ED-9415-9E9BBB2221F6Q38830111-AB811996-C097-4CE2-96C4-19E7A64CAB10Q39024201-405C826E-4B1C-4BF5-A7E0-B94000EDFD90Q39025320-DBA8C137-AC11-405E-9803-1F219F78A75DQ39689447-835D7BC7-E8B5-493B-B789-CE00077EF566
P50
description
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Rafael Esteban
@ast
Rafael Esteban
@en
Rafael Esteban
@es
Rafael Esteban
@nl
type
label
Rafael Esteban
@ast
Rafael Esteban
@en
Rafael Esteban
@es
Rafael Esteban
@nl
prefLabel
Rafael Esteban
@ast
Rafael Esteban
@en
Rafael Esteban
@es
Rafael Esteban
@nl
P1006
P214
P244
P950
P1006
P106
P1153
7101819740
P21
P214
P244
P31
P496
0000-0001-5280-392X
P734
P7859
lccn-n98093723